Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Chip array data for human PDAC Suit2-007 in primary (pancreas) secondary organs (liver and lungs) of a PDAC rat model

ABSTRACT: Chip array data for human PDAC Suit2-007 in primary (pancreas) secondary organs (liver and lungs) of a PDAC rat model

PROVIDER: PRJNA638930 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Chip array data for human PDAC Suit2-007 in primary (pancreas) secondary organs (liver and lungs) of a PDAC rat model

Project description:We report the gene expression profile of human PDAC Suit2-007 in primary (pancreas) secondary organs (liver and lungs) of a PDAC rat model

2020-09-01 | GSE152305 | GEO

Chip array data for Suit2-007 cells treated by riproximin (Rpx)

Project description:We report the effect of Rpx on human PDAC Suit2-007 cells after 48h time point

2020-09-01 | GSE152304 | GEO

Chip array data for Suit2-007 cells treated by riproximin (Rpx)

Project description:Chip array data for Suit2-007 cells treated by riproximin (Rpx)

| PRJNA638931 | ENA

ChIP-seq analysis of RARB enrichment in SUIT2 pancreatic cancer cells

Project description:The aim of the experiment was to identify genome wide binding sites for retinoic acid receptor beta (RARB) in RARB agonist treated human metastatic pancreatic ductal adenocarcinoma cells (SUIT2). Datasets are prsented for the ChIP-seq analysis for SUIT2 cells after 72 h treatment with either DMSO (vehicle control), 1 µM RAR-β agonist (CD 2314, Tocirs 3824), or 1 µM RAR-β antagonist (LE 135, Tocris 2021).

2023-05-01 | E-MTAB-12792 | biostudies-arrayexpress

Transcription profiling by array of two sub-clones of the SUIT2 pancreatic cancer cell line (S2-007 and S2-028) in order to identify metastasis-associated candidate genes.

Project description:S2-007 and S2-028 are cell lines derived from the same primary pancreatic adenocarcinoma, but displying strong differences in their invasive and metastatic potential both in vitro and in vivo. Three independent preparations each of the highly metastatic S2-007 and the low metastatic S2-028 cell line grown in 2D cell culture (DMEM (Gibco, Invitrogen, Carlsbad, CA) supplemented with 10% (v/v) fetal bovine serum (PAA, Pasching, Austria) in a humidified atmosphere and 5% CO2, 95% air at 37°C) were analyzed by expression profiling.

2015-02-25 | E-MTAB-3344 | biostudies-arrayexpress

RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines

Project description:RNA sequencing technology has been carried out in order to compare mRNA expression changes in epithelial BxPC-3 versus mesenchymal S2-007 cells.

2018-04-18 | GSE113259 | GEO

The nitrone compound OKN-007 delays motor neuron loss and disease progression in the G93A mouse model of Amyotrophic Lateral Sclerosis

Project description:Our study investigated the therapeutic potential of OKN-007 in the SOD1 G93A mouse model of amyotrophic lateral sclerosis (ALS). The impact of OKN-007, known for its antioxidant, anti-inflammatory, and neuroprotective properties, was tested at two doses (150 mg/kg and 300 mg/kg) at onset and late-stage disease. Results demonstrated a significant delay in disease progression at both doses, with treated mice showing a slower advance to severe disease stages compared to untreated controls. Transcriptomic analysis using bulk RNA sequencing identified dysregulated genes in G93A mice that were restored by OKN-007 treatment and pathways that showed altered expression in response to OKN-007. Overall, our findings suggest that OKN-007 holds potential as a disease-modifying treatment for ALS, although further research is needed to optimize dosing regimens and understand its long-term effects.

2024-11-10 | GSE281064 | GEO

Rhizobium sp. 007

Project description:Rhizobium sp. 007 Genome sequencing

| PRJNA674303 | ENA

Expression data from advanced stage of murine pancreatic ductal adenocarcinoma (PDAC) and control pancreas

Project description:We used microarrays to detail the global gene expression signature of PDAC and to identify distinct up- and down-regulated transcripts in these tumors compared to control pancreas. We also established from this dataset the metabolic signature of PDAC in order to define new metabolic therapeutic target for pancreatic cancer. PDAC were removed at an advanced stage of tumorigenesis in 7 to 10-weeks old mice with Mixed genetic background : B6CBAF1 x C57BL/6 x 129/Sv x FVB/n. Apparent signs used to determined the time of sacrifice : weight loss, lower activity and dull coat.

2014-09-16 | E-GEOD-61412 | biostudies-arrayexpress

Acidimicrobiales bacterium JGI 007

Project description:Acidimicrobiales bacterium JGI 007 Genome sequencing

| PRJNA372974 | ENA